Gastric inhibitory polypeptide receptor antagonist, SKL‐14959, suppressed body weight gain on diet‐induced obesity mice

OBJECTIVE: Gastric inhibitory polypeptide plays a role in glucose and lipid metabolism and is associated with obesity and insulin resistance. The objective of this study is to confirm the anti‐obesity effects of the gastric inhibitory polypeptide receptor antagonist, SKL‐14959, on diet‐induced obesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, T., Tanimoto, H., Mizuno, Y., Okamoto, M., Takeuchi, M., Tsubamoto, Y., Noda, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893465/
https://www.ncbi.nlm.nih.gov/pubmed/29670757
http://dx.doi.org/10.1002/osp4.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893465/
https://www.ncbi.nlm.nih.gov/pubmed/29670757
http://dx.doi.org/10.1002/osp4.164

Ejemplares similares